Dr. Joshua A. Jackman is an Associate Professor in the School of Chemical Engineering at Sungkyunkwan University (SKKU) in South Korea. He completed his B.S. degree in Chemistry from the University of Florida and started his Ph.D. studies in Medical Engineering and Medical Physics at the Harvard-MIT Division of Health Sciences and Technology. He later transferred to Nanyang Technological University (NTU) in Singapore where he completed his Ph.D. degree in Materials Science and Engineering. Subsequently, Dr. Jackman conducted his postdoctoral studies at the Stanford University School of Medicine.

At SKKU, Dr. Jackman leads a multidisciplinary group that applies interfacial science concepts to understand and engineer biomacromolecular interactions at phospholipid membranes. His work bridges fundamental membrane biophysics with translational applications spanning healthcare, food safety, and agriculture. Within the CellAg scope, his group has developed amphiphile mitigants that inhibit membrane-enveloped viruses and bacteria in biological matrices, and these efforts have led to widespread commercial adoption of monoglyceride-based mitigants for combating industry-related pathogens such as African swine fever virus (ASFV).

Dr. Jackman has published over 170 papers in top-tier journals such as Nature Materials, Nature Human Behaviour, Nature Communications, Journal of the American Chemical Society (JACS), Advances in Colloid and Interface Science, Transboundary and Emerging Diseases, and the Journal of Animal Science and Biotechnology (JASB). He is the recipient of scientific honors such as the BBA-Biomembranes Rising Star Award and JASB Best Paper Award. In addition, Dr. Jackman serves in advisory roles for global companies advancing innovation in lipid technology, biosensing, and agricultural biotechnology.

‍

ORCID:
‍https://orcid.org/0000-0002-1800-8102

Google Scholar:
‍https://scholar.google.com/citations?user=OIEzEOUAAAAJ&hl

‍